Pletal Cilostazol Improving Walking Ability and Reducing Leg Pain in PAD Patients

For individuals experiencing the discomfort and limitations of intermittent claudication, a symptom of peripheral artery disease (PAD), finding effective treatment is crucial. Pletal, with its active ingredient Cilostazol, offers a significant therapeutic option designed to improve walking distance and alleviate the associated pain and cramping. This detailed guide provides essential information about Pletal, helping you understand its benefits, how it works, and what to expect during treatment, ensuring you are well-informed about this important medication.

Pletal plays a vital role in enhancing the quality of life for many patients in the United States and beyond who suffer from intermittent claudication. By addressing the underlying issues that contribute to this condition, Pletal helps individuals regain mobility and reduce the pain that often restricts their daily activities. This comprehensive overview is intended to serve as a valuable resource for anyone considering or currently using Pletal for the management of their symptoms.

Understanding Pletal (Cilostazol) and Its Role

Pletal is a medication whose active ingredient is Cilostazol. It belongs to a class of drugs known as phosphodiesterase III (PDE3) inhibitors. Its primary mechanism of action involves increasing the levels of cyclic AMP (cAMP) in platelets and blood vessel walls. This leads to two main effects: vasodilation (widening of blood vessels) and inhibition of platelet aggregation (preventing blood clot formation).

The combined effect of improved blood flow and reduced platelet stickiness is particularly beneficial for patients with intermittent claudication, a condition characterized by pain, cramping, or tiredness in the legs and buttocks that occurs during walking or exercise and is relieved by rest. This symptom arises from a lack of adequate blood flow to the muscles, most commonly due to narrowing of the arteries in the legs, a condition known as peripheral artery disease (PAD).

By dilating the arteries, Pletal increases blood supply to the muscles in the legs, which can reduce the pain and cramping associated with claudication. Simultaneously, its antiplatelet effects help prevent the formation of new clots that could further impede blood flow. For patients in the US, Pletal represents a key therapeutic strategy to manage the challenging symptoms of intermittent claudication and improve their ability to walk longer distances without pain.

Indications for Pletal Use

Pletal is specifically indicated for the reduction of symptoms of intermittent claudication, as measured by an increase in the maximum walking distance and pain-free walking distance. It is not intended to replace other important treatments for peripheral artery disease (PAD), such as lifestyle modifications, management of risk factors (e.g., smoking cessation, control of diabetes and hypertension), and other medical therapies.

Treatment with Pletal should be considered as part of a comprehensive management plan for peripheral artery disease (PAD). The goal of therapy is to improve the patient’s functional capacity and quality of life by alleviating the painful and debilitating symptoms of intermittent claudication.

Dosage and Administration

The recommended dose of Pletal is 100 mg orally twice daily, taken at least half an hour before or two hours after breakfast and dinner. This specific timing relative to meals is crucial because high-fat meals can significantly increase the absorption of Cilostazol, potentially leading to higher plasma concentrations and an increased risk of side effects.

In some patients, particularly those with a higher propensity for adverse reactions, a dose reduction to 50 mg twice daily may be considered. It is important to adhere strictly to the prescribed dosage and administration instructions provided by a healthcare professional. Consistent use of Pletal is essential for achieving optimal therapeutic outcomes.

Important Safety Information: Warnings and Precautions

While Pletal offers significant benefits, it is important to be aware of certain warnings and precautions associated with its use.

• Contraindications: Pletal is contraindicated in patients with heart failure of any severity. This is because Cilostazol has phosphodiesterase III inhibitory activity, and drugs with similar activity have been shown to decrease survival in patients with class III-IV heart failure.
• Bleeding Risk: As Cilostazol has antiplatelet activity, it can increase the risk of bleeding. Patients should be monitored for signs of bleeding, particularly if they are also taking other medications that affect coagulation or platelet function, such as aspirin, clopidogrel, or anticoagulants like warfarin.
• Cardiac Effects: Pletal can cause tachycardia, palpitations, and arrhythmias. Patients with pre-existing cardiac conditions, especially those with severe unstable angina, myocardial infarction within the last 6 months, or severe supraventricular and ventricular arrhythmias, should be monitored closely.
• Drug Interactions: Cilostazol is metabolized by cytochrome P450 enzymes, particularly CYP3A4 and CYP2C19. Co-administration with strong inhibitors of these enzymes can significantly increase Cilostazol concentrations, potentially necessitating a dose reduction of Pletal. Examples include ketoconazole, itraconazole, erythromycin, diltiazem, and omeprazole. Grapefruit juice can also inhibit CYP3A4 and should be avoided or consumed with caution.
• Renal and Hepatic Impairment: Use Pletal with caution in patients with severe renal or hepatic impairment, as systemic exposure to Cilostazol and its active metabolites may be altered.
• Pregnancy and Lactation: The safety of Pletal in pregnant or lactating women has not been established. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown whether Cilostazol is excreted in human milk, and caution should be exercised if administered to a nursing woman.
• Other Considerations: Patients should be advised to report any unusual bleeding or bruising, chest pain, or changes in heart rate to their healthcare provider promptly.

Potential Side Effects

Like all medications, Pletal can cause side effects, although not everyone experiences them. The most common side effects are generally mild to moderate and often subside with continued treatment. Common side effects include:

• Headache
• Diarrhea
• Abnormal stools
• Palpitations
• Tachycardia (fast heart rate)
• Dizziness
• Peripheral edema (swelling in the hands or feet)
• Nausea
• Abdominal pain
• Rhinitis (runny nose)
• Pharyngitis (sore throat)
• Infection

Less common but more serious side effects may include bleeding events (e.g., gastrointestinal hemorrhage, intracranial hemorrhage), and liver function abnormalities. Patients should contact their healthcare provider if they experience any severe or persistent side effects, or any symptoms that cause concern. For residents of the US, detailed information on side effects can be found through official prescribing information and patient medication guides.

Drug Interactions

Pletal can interact with several other medications, which may alter the effects of either Pletal or the other drug. It is crucial to inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins.

• CYP3A4 and CYP2C19 Inhibitors: As mentioned, strong inhibitors of these enzymes (e.g., ketoconazole, itraconazole, fluconazole, erythromycin, clarithromycin, diltiazem, omeprazole, lansoprazole, grapefruit juice) can increase Cilostazol levels. A dose reduction of Pletal to 50 mg twice daily may be necessary when co-administered with these agents.
• Antiplatelet and Anticoagulant Agents: Concomitant use with other antiplatelet agents (e.g., aspirin, clopidogrel) or anticoagulants (e.g., warfarin, heparin) can increase the risk of bleeding. Close monitoring for signs of bleeding is recommended.
• Prostaglandin E1: There is a potential for enhanced antiplatelet effects when Cilostazol is co-administered with prostaglandin E1.

Overdose Information

In the event of an overdose of Pletal, symptoms may include severe headache, dizziness, tachycardia, and possibly severe diarrhea and vomiting. Supportive care should be provided. Gastric lavage and appropriate supportive measures may be necessary. Since Cilostazol is highly protein-bound, hemodialysis or peritoneal dialysis is unlikely to be effective in removing it from the body. Management of overdose should be supervised by a medical professional.

Storage and Handling

Pletal tablets should be stored at room temperature, ideally between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). Keep the medication in its original container, tightly closed, and protect it from light and moisture. Keep all medications out of the reach of children and pets. Do not use Pletal after the expiration date printed on the packaging.

Table: Characteristics of Pletal (Cilostazol)

Frequently Asked Questions (FAQ) About Pletal (Cilostazol)

Here are answers to some of the most common questions regarding Pletal:

1. How quickly does Pletal start to work?
   While some patients may notice improvements in walking distance within a few weeks, the full therapeutic effects of Pletal typically become evident after 4 to 12 weeks of consistent treatment. Maximum benefits, especially concerning sustained improvement in walking ability, can often take up to 6 months to develop. It is important to continue taking the medication as prescribed, even if immediate results are not apparent.

2. Can I take Pletal with food?
   No, it is generally recommended to take Pletal at least half an hour before or two hours after meals (specifically breakfast and dinner). Taking Pletal with a high-fat meal can significantly increase the absorption of Cilostazol, leading to higher levels in the body and potentially increasing the risk of side effects. Adhering to the empty stomach recommendation helps ensure consistent and safe drug levels.

3. What should I do if I miss a dose of Pletal?
   If you miss a dose of Pletal, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up. Consistent dosing is important for maintaining effective blood levels of the medication.

4. Are there any lifestyle changes I should make while taking Pletal?
   Yes, Pletal is most effective as part of a comprehensive treatment plan for intermittent claudication. This typically includes lifestyle modifications such as quitting smoking (which is crucial for PAD), regular exercise (walking programs often recommended), a heart-healthy diet, and managing underlying conditions like diabetes, high blood pressure, and high cholesterol. Your healthcare provider can offer personalized advice on these changes.

5. Can Pletal cause problems with my heart?
   Pletal can cause changes in heart rate, including an increase in heart rate (tachycardia) or palpitations. It is contraindicated in patients with heart failure due to concerns observed with other similar drugs. If you have a history of heart conditions or experience chest pain, shortness of breath, or new heart rhythm disturbances while taking Pletal, you should contact your healthcare provider immediately.

6. What are the most common side effects of Pletal?
   The most common side effects reported with Pletal include headache, diarrhea, abnormal stools, palpitations (a sensation of a rapid or irregular heartbeat), and dizziness. These side effects are often mild to moderate and may decrease as your body adjusts to the medication. If any side effects become severe or persistent, consult your healthcare provider.

7. Is Pletal a blood thinner?
   Pletal has antiplatelet activity, meaning it helps prevent blood platelets from sticking together and forming clots. While it shares some characteristics with “blood thinners” (anticoagulants) in reducing clotting risk, its mechanism is distinct. It is important to inform your doctor if you are taking other antiplatelet medications (like aspirin or clopidogrel) or anticoagulants (like warfarin) as combining these can increase the risk of bleeding.

8. Can I drink alcohol while taking Pletal?
   It is generally advisable to limit or avoid alcohol consumption while taking Pletal. Alcohol can potentially exacerbate some of Pletal‘s side effects, such as dizziness or gastrointestinal upset. Always discuss alcohol consumption with your healthcare provider to understand any specific risks for your situation.

9. How long do I need to take Pletal?
   Treatment with Pletal for intermittent claudication is often long-term, as it aims to manage the chronic symptoms of peripheral artery disease. The duration of treatment will be determined by your healthcare provider based on your response to the medication and your overall clinical condition. Do not stop taking Pletal without consulting your doctor.